Heart failure and atrial fibrillation (AF) frequently coexist and AF worsens heart failure prognosis. Device-based diagnostics derived from implantable cardioverter-defibrillator (ICD) interrogation provide an accurate method for detecting AF episodes. This study sought to determine clinical and echocardiographic predictors of AF occurrence, including an index of total atrial conduction time derived by tissue Doppler imaging (PA-TDI duration), in patients with heart failure. Moreover, the role of PA-TDI duration on the prediction of AF occurrence in subgroups of patients with and without history of AF was explored.
introduction
Atrial fibrillation (AF) is a frequent arrhythmia associated with increased cardiovascular morbidity and mortality. 1, 2 In particular, AF is well known to result in a substantially increased risk for stroke. 3 Heart failure is a serious condition frequently associated with AF. 4 In particular, AF may further worsen the long-term prognosis of heart failure by increasing the risk of cardiac thromboembolism. [4] [5] [6] Thus, the identification of predictors of AF occurrence in heart failure patients is crucial for the initiation of prophylactic oral anticoagulant therapy in order to reduce the risk of cardiogenic stroke.
Recently, a novel non-invasive echocardiographic index derived by tissue Doppler imaging was demonstrated to predict AF occurrence in a heterogeneous patient population. 7 Merckx et al. showed that the time-interval from the beginning of the electrocardiogram P wave and the peak of A' LATERAL wave on tissue Doppler images (PA-TDI duration) provided a good estimation of the total atrial conduction time. 8 In addition, de Vos et al. demonstrated the independent association between PA-TDI duration and AF occurrence in patients without history of AF. 7 However, the capability of this index (PA-TDI duration) to predict AF in heart failure patients with and without history of AF still remains unknown. Furthermore, it should be emphasized that clinical follow-up based on history of AF related symptoms fails to identify asymptomatic AF episodes. These asymptomatic episodes have been shown to be present in almost 20% of patients with paroxysmal AF and they have important prognostic clinical implications. 9, 10 Device-based diagnostics derived from pacemaker or implantable cardioverter-defibrillator (ICD) interrogation provide an accurate method for detecting asymptomatic AF episodes. 9, 10 Accordingly, in order to detect all AF episodes including the asymptomatic AF episodes, a cohort of heart failure patients who had undergone ICD implantation was studied, and AF episodes were identified by ICD interrogation.
The aims of the present study were two-fold. Firstly, to identify clinical, and/or echocardiographic predictors of AF occurrence, including left atrial (LA) volumes, LA function and PA-TDI duration, in patients with heart failure. Secondly, the role of PA-TDI duration on the prediction of AF occurrence was explored in the subgroups of patients with and without history of AF.
MetHods

Patient population and protocol
A total of 627 consecutive patients with mild to severe heart failure scheduled for ICD implantation for primary or secondary prevention according to the current AHA/ACC/ ESC guidelines were included.
11 Exclusion criteria were: 1) absence of normal sinus rhythm during echocardiographic examination; 2) acoustic window with poor image quality.
All patients underwent a complete baseline history taking and physical examination, 12-lead electrocardiogram and transthoracic echocardiogram prior to ICD implantation. History of AF, defined as documented AF on surface ECG or ECG-Holter monitoring was collected. In addition, history of AF was divided into persistent and paroxysmal AF. Specifically, history of persistent AF was defined based on the requirement for pharmaceutical or electrical cardioversion. Conversely, paroxysmal AF did not require pharmaceutical or electrical cardioversion. 5 Patients with permanent AF were excluded from the study because of the absence of normal sinus rhythm during the echocardiographic examination.
Baseline clinical variables recorded included New York Heart Association (NYHA) functional class, cardiac risk factors and consequent CHADS 2 score 5 , and medication. Baseline electrocardiographic variables recorded included heart rate, PR interval, QRS duration, and corrected QT interval calculated by Bazett's formula (corrected QT=QT/√ RRinterval). Baseline echocardiographic parameters of systolic and diastolic function were included. Furthermore, the total atrial conduction time was estimated with tissue Doppler imaging (PA-TDI duration), as previously described 8 . All baseline clinical, electrocardiographic and echocardiographic analyses were performed by independent blinded observers.
All patients were prospectively followed up after ICD implantation for AF occurrence recorded by ICD. AF occurrence after ICD implantation was defined as atrial high-rate episodes (>180 bpm) lasting at least 10 minutes in patients with cardiac resynchronization therapy and dual-chamber devices. In patients with single-chamber devices, AF occurrence was defined based on ICD interrogation with device-based diagnostics. 12, 13 From the various clinical, electrocardiographic and echocardiographic variables recorded, independent predictors of AF occurrence were identified. The patients were subsequently divided in 2 subgroups based on the history of AF (present or absent) and independent predictors of AF occurrence were identified in each subgroup.
echocardiography
All patients were imaged in the left lateral decubitus position using a commercially available system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, USA). Standard 2-dimensional images were obtained using a 3.5-MHz transducer and, digitally stored in cine-loop format; the analysis was performed offline using EchoPAC version 108.1.5 (General Electric-Vingmed). From the standard apical views (4-and 2-chamber) left ventricular volumes and left ventricular ejection fraction were calculated according to the American Society of Echocardiography guidelines.
14 Severity of mitral regurgitation was graded semi-quantitatively from colour-flow Doppler data using the 4-chamber apical views according to the ACC/AHA guidelines. 15 Mitral regurgitation was classified as mild (jet area/left atrial area <20%), moderate (jet area/left atrial area 20-40%) and severe (jet area/left atrial area >40%).
Left atrial volumes (LAVs) were calculated from the 4-and 2-chamber apical views as recommended by the American Society of Echocardiography guidelines.
14 LAVs were measured at 3 time points during the cardiac cycle: 1) maximum LAV (LAVmax) at end-systole, just before mitral valve opening; 2) minimum LAV (LAVmin) at end-diastole, just before mitral valve closure; 3) LAV before atrial active contraction 16, 17 Spectral Doppler velocities were measured from the apical 4-chamber view using a 2 mm sample volume positioned at the mitral leaflet tips. Peak transmitral early (E wave) and atrial (A wave) mitral velocities, and the E wave deceleration time were obtained. Doppler tracings were obtained in accordance to the recommendations of the American Society of Echocardiography.
14 Colour-coded tissue Doppler images of the left ventricle obtained in the apical 4-chamber view were acquired at high frame rates (at least 150 frames/s) during end-expiration. Early diastolic myocardial velocities (E') were determined at the septal and lateral sides of the mitral annulus (E' SEPTAL , E' LATERAL ). E' MEAN was calculated as (E' SEPTAL +E' LATERAL )/2. 18 Total atrial conduction time was estimated with colour-coded tissue Doppler images by first placing the sample size on the LA lateral wall just above the mitral annulus. Next, the time-interval from the onset of the P-wave on lead II of the electrocardiogram (on echocardiographic images) to the peak of A' LATERAL wave (PA-TDI duration) was measured ( Figure 1 ). 8 Bland-Altman analysis demonstrated a good intra-observer and inter-observer agreements with a non-significant bias for PA-TDI duration measurement. Mean differences ± 2 standard deviations for PA-TDI duration were 1.8 ± 10 ms for intraobserver agreement and 1.7 ± 10 ms for inter-observer agreement. 
statistical analysis
Continuous data are presented as mean ± SD and categorical data are presented as frequencies and percentages. All continuous variables were evaluated for normal distribution with Kolmogorov-Smirnov tests. Unpaired T test and Mann-Whitney Utest were used to compare continuous variables between patients with vs. without AF occurrence and between patients with vs. without history of AF, as appropriate. Chi-square test was used to compare categorical variables between patients with vs. without AF occurrence and between patients with vs. without history of AF. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify clinical and echocardiographic predictors of AF occurrence. Only significant (p <0.05) univariable predictors were entered as covariates in the multivariable analysis, which was performed using the enter model. Hazard ratios and 95% confidence intervals (CI) were calculated. Time to first episode of atrial fibrillation in relation to PA-TDI duration was analyzed with the Kaplan-Meier method and compared with the log-rank test. Therefore, PA-TDI was dichotomized based on the median (139 ms). Similarly to the overall patient population, univariable and multivariable Cox proportional hazards regression analyses were used to identify predictors of AF occurrence in the subgroups of patients with and without history of AF. For all the multivariable Cox proportional hazards regression analyses a correlation coefficient of <0.7 (corresponding to a tolerance of >0.5) was set to avoid multicollinearity between the univariable predictors. To increase clinical utility, the hazard ratios and 95% CI of LAVmin PA-TDI duration were reported as per 10 ml/m 2 increase and per 20 ms increase, respectively. A 2-tailed p value of <0.05 was considered significant. All statistical analyses were performed using SPSS for Windows (SPSS Inc, Chicago), version 16.
resuLts
In total 495 patients were included in the analysis: 94 patients were excluded due to the absence of normal sinus rhythm during the echocardiographic examination and 38 patients were excluded because of suboptimal image quality. Primary prevention of sudden cardiac death was the reason for implantation in 434 (88%) of the patients, whereas 61 (12%) patients were implanted for secondary prevention of sudden cardiac death. Overall, 481 (97%) patients were implanted with cardiac resynchronization therapy or dual-chamber ICD devices; whereas only 14 (3%) patients got a singlechamber ICD device.
The general characteristics of the patient population are reported in Tables 1-3 . The mean age of the overall population was 62±12 years, and 21% of the patients were women. A history of AF was present in 102 (21%) patients and, the majority of the patients had high thromboembolic risk according to the CHADS 2 score (2.2±1.1). The mean QRS duration was 128±32 ms, and 61% of the patients received a cardiac resynchronization therapy device. Most of the patients were treated with angiotensin converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and diuretics (84%, 69%, and 73%, respectively). All of the patients had dilated left ventricles (left ventricular end-diastolic volume = 95±35 ml/m 2 ) with depressed left ventricular ejection fraction (29±6%). Similarly, the LA was significantly dilated (LAVmax = 31±13 ml/m 2 ) and LA function was reduced (total LA emptying fraction = 43±15%). Finally, the total atrial activation time expressed as PA-TDI duration was 141±26 ms. 
Patients with vs. patients without af occurrence
There were no differences in age between patients with and patients without AF occurrence. The percentage of women was higher in the group with AF occurrence as compared to the group without AF occurrence (30% vs. 18%, p = 0.004) as was the history of AF (41% vs. 13%, p <0.001). NYHA functional class was higher in patients with AF occurrence as compared to the patients without AF occurrence (2.4±0.8 vs.
2.2±0.8, p = 0.023). In addition, 70% of the patients with AF occurrence received a cardiac resynchronization therapy device, whereas only 58% of the patients without AF occurrence received a cardiac resynchronization therapy device (p = 0.016; Table 1 ). The use of medications was different for beta-blockers (lower in patients with AF occurrence, p = 0.006), diuretics/aldosterone antagonists (higher for the patients with AF occurrence, p = 0.046), and for statins (lower for the patients with AF occurrence, p = 0.018; Table 2 ).
Regarding the echocardiographic characteristics, patients with AF occurrence as compared to the patients without AF occurrence had larger LAVmax (34±16 ml/m2 vs. 30±12 ml/m2, p = 0.003), LAVmin (21±13 ml/m2 vs. 17±10 ml/m2, p = 0.001), LAVpre-A (24±14 ml/m2 vs. 21±10 ml/m2, p = 0.010). In addition, LA booster function was more depressed in patients with AF occurrence (18±11% vs. 21±12%, p = 0.007). Finally, PA-TDI duration was longer in patients with AF occurrence as Figure 1 ).
Predictors of af occurrence in the overall patient population
A total ofOverall 142 of the 495 (29%) patients experienced a first AF episode during a mean follow-up of 16.4±11.2 months. To identify independent predictors of AF during follow-up, univariable predictors with a p-value <0.05 were entered into the Cox proportional-hazard model as covariates.
On multivariable analysis, female gender (hazard ratio, 1.60; 95% CI, 1.09-2.35; p = 0.017), history of AF (hazard ratio, 2.22; 95% CI, 1.51-3.27; p <0.001), and PA-TDI duration (hazard ratio per 20 ms increase, 1.27; 95% CI, 1.13-1.42; p <0.001), were independently associated with AF occurrence during follow-up (Table 4) .
When the patient population was dichotomized based on the median PA-TDI duration (139 ms), the Kaplan-Meier curve demonstrated that patients with longer PA-TDI duration experienced significantly higher AF occurrence as compared to patients with shorter PA-TDI duration (log rank p <0.001; Figure 2 ). In particular, a cumulative 18%, 30%, and 44% of patients with longer PA-TDI experienced AF occurrence at 6, 12 and 18 months follow-up, respectively. In contrast, a respective 10%, 13%, and 18% of patients with shorter PA-TDI duration experienced AF occurrence during the same time period. Figures 3A and 3B show the Kaplan-Meier curves for the other 2 variables independently related to AF occurrence during follow-up: female gender and history of AF. 
Patients with vs. patients without history of af
From According to the baseline clinical history, a total of 102 (21%) patients had a history of AF. Of the 102 patients with history of AF, 56 (55%) had history of paroxysmal AF and 46 (45%) of persistent AF. Specifically, AF occurrence during follow-up was higher in patients with history of persistent AF as compared to paroxysmal AF (70% vs. 46%, p = 0.019). There were no differences in the clinical characteristics between patients with and without history of AF except for age, patients with history of AF were older than the patients without history of AF (65±10 vs. 61±12 years, p = 0.005).
In addition, patients with history of AF were most often treated with antiarrhythmic drugs and oral anticoagulants (43% vs. 14%, p <0.001 and 64% vs. 51%, p <0.001, respectively), whereas the use of aspirin was larger in patients without history of AF (45% vs. 32%, p = 0.021).
Regarding the echocardiographic characteristics, as compared to the patients without history of AF, the patients with history of AF had larger LAV (37±18 ml/m 2 vs. 30±12 ml/m 2 , p <0.001 for LAVmax, 24±14 ml/m 2 vs. 17±9 ml/m 2 , p <0.001 for LAVmin, 28±15 ml/m 2 vs. 21±10 ml/m 2 , p <0.001 for LAVpre-A) and poorer LA functions (38±15% vs. 45±14%, p <0.001 for total LA empting function, 72±50% vs. 97±62%, p <0.001, for LA reservoir function, 27±13% vs. 30±13%, p = 0.028, for LA conduit function, 15±10% vs. 22±12%, p <0.001, for LA booster function). In addition, PA-TDI duration was significantly longer in patients with history of AF as compared to the patients without history of AF (159±32 ms vs. 136±22 ms, p <0.001).
Predictors of AF occurrence in patients without history of AF
To identify independent predictors of AF during follow-up in patients without history of AF, significant univariable predictors were entered into the Cox proportional-hazard model as covariates. On multivariable analysis, female gender (hazard ratio, 1.95; 95% CI, 1.22-3.10; p = 0.005), and PA-TDI duration (hazard ratio per 20 ms increase, 1.34; 95% CI, 1.13 to 1.58; p = 0.001), were independently associated with AF occurrence during follow-up (Table 5 ). Figure 4A shows the Kaplan-Meier curves for the PA-TDI duration in patients without history of AF. 
Predictors of AF occurrence during follow-up in patients with history of AF
To identify independent predictors of AF during follow-up in patients with history of AF, significant univariable predictors were entered into the Cox proportional-hazard model as covariates. On multivariable analysis, cardiac resynchronization device therapy (hazard ratio, 2.67; 95% CI, 1.39-5.10; p = 0.003), and PA-TDI duration (hazard ratio per 20 ms increase, 1.19; 95% CI, 1.03 to 1.38; p = 0.022), were independently associated with AF occurrence during follow-up (Table 6 ). Figure 4B shows KaplanMeier curves for the PA-TDI duration in patients with history of AF.
discussion
The main findings of the present study are: 1) the independent predictors of AF occurrence in advanced heart failure patients were female gender, history of AF and PA-TDI duration; 2) in the subgroups of patients with and without history of AF, PA-TDI duration remained an independent predictor of AF occurrence during follow-up.
Heart failure and af
Heart failure and AF are two disorders that frequently coexist. Indeed, many clinical conditions such as age, hypertension, diabetes and coronary artery disease are common risk factors for both AF and heart failure. 19 Moreover, in heart failure patients conditions such as atrial enlargement or poor atrial function related to the remodelling processes may predispose to AF occurrence. 6 In addition, previous studies have shown that heart failure patients who develop AF have a worse prognosis than heart failure patients free from AF. 1, [20] [21] [22] [23] Therefore, the identification of heart failure patients at higher risk for AF occurrence may be useful in order to initiate early prophylactic therapies and improve the long-term outcome of these patients.
process is the ability to identify all of the AF episodes in these patients. In particular, asymptomatic AF episodes may be misclassified during clinical follow-up and it has been shown that these asymptomatic AF episodes may have relevant AF-related complications similar to overt, symptomatic AF episodes. 24, 25 Interrogation of newer more sophisticated pacemaker or ICD devices allows the detection of asymptomatic AF episodes. 9, 26 A study by Glotzer et al. 9 demonstrated that in patients with a pacemaker for sinus node dysfunction the atrial high rate events detected by pacemaker interrogation were significantly related to the risk of death or stroke. However, the interrogation of the device to classify AF episodes can be applied only in patients with a pacemaker or ICD. Therefore, in the current study, heart failure patients selected for ICD implantation were recruited in order to detect all the AF episodes, including the asymptomatic episodes, through the ICD interrogation.
Predictors of af occurrence in the overall heart failure patient population
In the present study, clinical and echocardiographic predictors of AF occurrence in heart failure patients were explored. In particular, among the clinical predictors, female gender and history of AF were confirmed to be independently associated with AF occurrence. 5 Among the echocardiographic variables, LA volumes and booster function together with PA-TDI duration were associated with AF occurrence at univariable analysis. However, at multivariable analysis only PA-TDI duration was an independent echocardiographic predictor of AF occurrence (adjusted hazard ratio = 1.27, 95% CI 1.13-1.42, p <0.001). This finding underlines that a surrogate of the total atrial conduction time like PA-TDI was a stronger predictor of AF occurrence as compared to LA volumes and LA function. A possible explanation may be that the LA remodelling present in heart failure patients is associated with an increased risk of the development of AF. The remodelling process causes an increase in LA volumes, with a deterioration in LA function and an increase in LA fibrosis. Both LA enlargement and LA fibrosis may promote the occurrence of AF in these patients. 27 The total atrial conduction time (PA-TDI duration) may be influenced not only by LA enlargement but also by LA fibrosis which may further slow down the electrical atrial conduction. Therefore, PA-TDI duration may be more strongly related to AF occurrence than measurement of LA volumes or function.
Pa-tdi duration as a predictor of af occurrence in the subgroup without history of af
Previous studies have explored the role of total atrial conduction time detected with tissue Doppler imaging for the prediction of AF occurrence in patients without history of AF. 7, 28 In particular, de Vos et al. used the PA-TDI duration to predict AF occurrence in 249 patients with preserved ejection fraction (60±10%) referred for a standard echocardiographic examination. The authors demonstrated that PA-TDI duration was independently related to AF occurrence during follow-up. In the present study, 393 of the heart failure patients had no previous history of AF and the mean ejection fraction in this subgroup of patients was 29±10%. PA-TDI was still an independent predictor of AF occurrence during follow-up. Therefore, the current study highlights that PA-TDI is also an important predictor of AF occurrence in heart failure patients with depressed left ventricular ejection fraction, extending previous results in different patient populations. 7, 28 Pa-tdi duration as a predictor of af occurrence in the subgroup with history of af
In the present study a total of 102 heart failure patients had a history of AF. The analysis of this subset of patients underlined that PA-TDI duration was still an independent predictor of AF occurrence together with implantation of a cardiac resynchronization therapy device. Patients selected for cardiac resynchronization therapy were characterized by more advanced heart failure, a condition shown to be an important predictor of AF occurrence. 4, 5 In addition, the relevance of measuring PA-TDI duration in these patients is stressed by previous findings. 29 Specifically, Buck et al. reported that an estimation of total atrial conduction time with PA-TDI may have great relevance for the selection of advanced heart failure patients who will be amenable to cardiac resynchronization therapy. 29 The finding that PA-TDI duration was again independently associated with AF occurrence during follow-up shows for the first time the relevance of this index even in patients with history of AF. Therefore, PA-TDI duration may be useful for the risk-stratification of heart failure patients with or without history of AF.
clinical implications
Early risk stratification for AF occurrence is very important, especially in heart failure patients who have increased risk of thromboembolic complications during AF. The present study has demonstrated that PA-TDI duration can predict AF occurrence in heart failure patients. However, future large randomized trials are needed to clarify the potential relation between PA-TDI duration and thromboembolic complications during AF in heart failure patients.
